Global Live Cell Imaging Markets, 2022-2027 – Opportunities in Applications of HCS in Personalized Medicine – ResearchAndMarkets.com


DUBLIN–(BUSINESS WIRE)–The “Global Live Cell Imaging Market (2022-2027) by Product & Service, Application, Technology, End-User, Geography, Competitive Analysis, and Impact of Covid-19 with Ansoff Analysis” report has been added to from ResearchAndMarkets.com offer.

The Global Live Cell Imaging Market is estimated to be valued at USD 2.07 Billion in 2022 and is projected to reach USD 2.99 Billion by 2027, growing at a CAGR of 7.6%.

Market dynamics are forces that are impacting pricing and stakeholder behaviors in the global Live Cell Imaging market. These forces create price signals that result from changes in the supply and demand curves for a given product or service.

The forces of market dynamics can be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand and supply. Human emotions can also drive decisions, influence the market and create price signals.

As market dynamics impact supply and demand curves, policymakers aim to determine how best to use various financial tools to stem various strategies aimed at accelerating growth and reducing risk.

Company Profiles

Some of the companies covered in this report are Biotek Instruments, Becton, Dickinson & Company, Bruker, Carl Zeiss, Cytosmart, Danaher, GE Healthcare, Sony Biotechnology, Thermo Fisher Scientific, etc.

The report provides a detailed analysis of competitors in the market. It covers the analysis of financial performance of listed companies in the market. The report also offers detailed information about recent development and competitive scenario of the companies.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and assess the position of companies based on their industry position score and market performance score.

The tool uses various factors to classify players into four categories. Some of these factors considered for analysis are financial performance over the past 3 years, growth strategies, innovation score, new product launches, investments, market share growth, etc

Ansoff analysis

The report presents a detailed analysis of the Ansoff matrix for the global live cell imaging market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design business growth strategies.

The matrix can be used to assess approaches in four strategies viz. Market development, market penetration, product development and diversification. The matrix is ​​also used for risk analysis to understand the risk associated with each approach.

The report analyzes the global Live Cell Imaging market using the Ansoff Matrix to provide the best approaches a company can take to improve its position in the market.

Market dynamics

Drivers

  • Increased Adoption of High-Content Screening Techniques in Drug Discovery

  • Growing incidence of cancer

  • Increase the availability of research funds

  • Increased government funding in regenerative medicine research

Constraints

  • High cost of high content screening systems

Opportunities

  • Applications of HCS in Personalized Medicine

Challenges

  • Maintenance of cell viability and cell environment in cell cultures

  • Lack of qualified professionals

Market segmentation

  • By product and service, the market is categorized into instruments, consumables, software and services.

  • By Application, the market is categorized into cell biology, stem cells, developmental biology, and drug discovery.

  • By Technology, the market is categorized into accelerated microscopy, fluorescence resonance energy transfer (FRET), fluorescence recovery after photobleaching (FRAP), high content screening (HCS) and others.

  • By Final user, the market is categorized into pharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations.

  • By Geography, the market is categorized into Americas, Europe, Middle East & Africa, and Asia-Pacific.

Company Profiles

  • Biotek instruments

  • Becton, Dickinson & Company

  • Brucker

  • Carl Zeiss

  • Cytosmart

  • Danaher

  • Etaluma

  • GE Healthcare

  • Cleence

  • Biosystems Logos

  • Merck Kgaa

  • Nanoentek

  • Nanoolive

  • Nikon

  • Perkinelmer

  • Phase focus

  • Sartorius

  • Sony Biotechnology

  • Thermo Fisher Scientific

For more information on this report, visit https://www.researchandmarkets.com/r/4wo21m

Previous Can we still learn something? – OpEd – Eurasia Review
Next The integration of gene therapy for rare diseases